Possibly, this demonstrates, (1) the high sensitivity of several hematological tumors to standard-of-care remedies, and/or (2) the actual fact that hematological malignancies frequently stem from the different parts of the disease fighting capability, leading to compromised immune features and limited susceptibility to multiple types of immunotherapy and immunogenic chemotherapy.279,280 In multiple clinical research, ICD-inducing chemotherapeutic … Continue reading Possibly, this demonstrates, (1) the high sensitivity of several hematological tumors to standard-of-care remedies, and/or (2) the actual fact that hematological malignancies frequently stem from the different parts of the disease fighting capability, leading to compromised immune features and limited susceptibility to multiple types of immunotherapy and immunogenic chemotherapy